Evaluation of LVAD infections in a tertiary university hospital cohort

AIM: This study aims to evaluate driveline infections in ourcenter in terms of pathogens and resistance patterns. BACKGROUND: The use of left ventricular assist devices (LVAD) is increasing for bridging therapy inpatients who cannot undergo heart transplantation or for long-term therapy in patients...

Full description

Saved in:
Bibliographic Details
Main Authors: Ümit Kahraman, Oğuzhan Acet, Hasip Kahraman, Muhammed Alper Özarslan, Derya Kaya, Oğuz Reşat Sipahi, Meltem Taşbakan, Mustafa Özbaran, Tahir Yağdıç, Çağatay Engin
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716524003175
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850050758469222400
author Ümit Kahraman
Oğuzhan Acet
Hasip Kahraman
Muhammed Alper Özarslan
Derya Kaya
Oğuz Reşat Sipahi
Meltem Taşbakan
Mustafa Özbaran
Tahir Yağdıç
Çağatay Engin
author_facet Ümit Kahraman
Oğuzhan Acet
Hasip Kahraman
Muhammed Alper Özarslan
Derya Kaya
Oğuz Reşat Sipahi
Meltem Taşbakan
Mustafa Özbaran
Tahir Yağdıç
Çağatay Engin
author_sort Ümit Kahraman
collection DOAJ
description AIM: This study aims to evaluate driveline infections in ourcenter in terms of pathogens and resistance patterns. BACKGROUND: The use of left ventricular assist devices (LVAD) is increasing for bridging therapy inpatients who cannot undergo heart transplantation or for long-term therapy in patients who are not suitable for heart transplantation. The most common complication after LVAD implantation is driveline infections. METHODS: We retrospectively evaluated LVAD patients implanted at our center between 01.01.2010 and 20.11.2023. Patients with drive-line infection findings and microbiological growth in the drive-line exit site culture were included in the study. Microbiological culture wgrowths, bacteremia rates, and resistance patterns of pathogens were evaluated. RESULTS: LVAD implantation was performed in 124 patients between the specified dates. In 109 patients [21 women (19.2%), mean age 50.9±12.45, years ranging 18-71], culture growth, which can be associated with LVAD,was observed in the drive-line exit site (n:94-86.2%), peripheral blood culture (55-50.4%), or both (52-47.7%). In 57 (52.2%) patients,multiple microorganisms were grown in the culture of the driveline exit area.In 15 (13.7%) patients, multiple microorganisms were grown in the peripheral blood cultures. The microorganisms are shown in Table 1.Etiological agents and resistance patterns of the microorganisms are shown in Table 2. During the follow-up period, the swab culture growths of 52 patients and the peripheral blood culture of 41 patients were eradicated. The five-year survival rate after LVAD implantation was 58/109(53.2%). CONCLUSIONS: LVAD-associated infections and antibiotic-resistant microorganisms are common in LVAD-implanted patients. When choosing antibiotics for LVAD-related infections, it is important to consider local hospital information.
format Article
id doaj-art-3a5b3312c0cb4cc9a8d13263ef2454c4
institution DOAJ
issn 2213-7165
language English
publishDate 2024-12-01
publisher Elsevier
record_format Article
series Journal of Global Antimicrobial Resistance
spelling doaj-art-3a5b3312c0cb4cc9a8d13263ef2454c42025-08-20T02:53:21ZengElsevierJournal of Global Antimicrobial Resistance2213-71652024-12-0139434410.1016/j.jgar.2024.10.140Evaluation of LVAD infections in a tertiary university hospital cohortÜmit Kahraman0Oğuzhan Acet1Hasip Kahraman2Muhammed Alper Özarslan3Derya Kaya4Oğuz Reşat Sipahi5Meltem Taşbakan6Mustafa Özbaran7Tahir Yağdıç8Çağatay Engin9Department of Cardiovascular Surgery, Ege University, İzmir, TurkiyeDepartment of Infectious Diseases and Clinical Microbiology, Ege University, İzmir, TurkiyeDepartment of Infectious Diseases and Clinical Microbiology, Eskişehir Osmangazi University, Eskişehir, TurkiyeDepartment of Medical Microbiology, Ege University, İzmir, TurkiyeDepartment of Infectious Diseases and Clinical Microbiology, Ege University, İzmir, TurkiyeDepartment of Infectious Diseases and Clinical Microbiology, Ege University, İzmir, TurkiyeDepartment of Infectious Diseases and Clinical Microbiology, Ege University, İzmir, TurkiyeDepartment of Cardiovascular Surgery, Ege University, İzmir, TurkiyeDepartment of Cardiovascular Surgery, Ege University, İzmir, TurkiyeDepartment of Cardiovascular Surgery, Ege University, İzmir, TurkiyeAIM: This study aims to evaluate driveline infections in ourcenter in terms of pathogens and resistance patterns. BACKGROUND: The use of left ventricular assist devices (LVAD) is increasing for bridging therapy inpatients who cannot undergo heart transplantation or for long-term therapy in patients who are not suitable for heart transplantation. The most common complication after LVAD implantation is driveline infections. METHODS: We retrospectively evaluated LVAD patients implanted at our center between 01.01.2010 and 20.11.2023. Patients with drive-line infection findings and microbiological growth in the drive-line exit site culture were included in the study. Microbiological culture wgrowths, bacteremia rates, and resistance patterns of pathogens were evaluated. RESULTS: LVAD implantation was performed in 124 patients between the specified dates. In 109 patients [21 women (19.2%), mean age 50.9±12.45, years ranging 18-71], culture growth, which can be associated with LVAD,was observed in the drive-line exit site (n:94-86.2%), peripheral blood culture (55-50.4%), or both (52-47.7%). In 57 (52.2%) patients,multiple microorganisms were grown in the culture of the driveline exit area.In 15 (13.7%) patients, multiple microorganisms were grown in the peripheral blood cultures. The microorganisms are shown in Table 1.Etiological agents and resistance patterns of the microorganisms are shown in Table 2. During the follow-up period, the swab culture growths of 52 patients and the peripheral blood culture of 41 patients were eradicated. The five-year survival rate after LVAD implantation was 58/109(53.2%). CONCLUSIONS: LVAD-associated infections and antibiotic-resistant microorganisms are common in LVAD-implanted patients. When choosing antibiotics for LVAD-related infections, it is important to consider local hospital information.http://www.sciencedirect.com/science/article/pii/S2213716524003175Left Ventricular Assist DeviceHeart FailureDriveline Infections
spellingShingle Ümit Kahraman
Oğuzhan Acet
Hasip Kahraman
Muhammed Alper Özarslan
Derya Kaya
Oğuz Reşat Sipahi
Meltem Taşbakan
Mustafa Özbaran
Tahir Yağdıç
Çağatay Engin
Evaluation of LVAD infections in a tertiary university hospital cohort
Journal of Global Antimicrobial Resistance
Left Ventricular Assist Device
Heart Failure
Driveline Infections
title Evaluation of LVAD infections in a tertiary university hospital cohort
title_full Evaluation of LVAD infections in a tertiary university hospital cohort
title_fullStr Evaluation of LVAD infections in a tertiary university hospital cohort
title_full_unstemmed Evaluation of LVAD infections in a tertiary university hospital cohort
title_short Evaluation of LVAD infections in a tertiary university hospital cohort
title_sort evaluation of lvad infections in a tertiary university hospital cohort
topic Left Ventricular Assist Device
Heart Failure
Driveline Infections
url http://www.sciencedirect.com/science/article/pii/S2213716524003175
work_keys_str_mv AT umitkahraman evaluationoflvadinfectionsinatertiaryuniversityhospitalcohort
AT oguzhanacet evaluationoflvadinfectionsinatertiaryuniversityhospitalcohort
AT hasipkahraman evaluationoflvadinfectionsinatertiaryuniversityhospitalcohort
AT muhammedalperozarslan evaluationoflvadinfectionsinatertiaryuniversityhospitalcohort
AT deryakaya evaluationoflvadinfectionsinatertiaryuniversityhospitalcohort
AT oguzresatsipahi evaluationoflvadinfectionsinatertiaryuniversityhospitalcohort
AT meltemtasbakan evaluationoflvadinfectionsinatertiaryuniversityhospitalcohort
AT mustafaozbaran evaluationoflvadinfectionsinatertiaryuniversityhospitalcohort
AT tahiryagdıc evaluationoflvadinfectionsinatertiaryuniversityhospitalcohort
AT cagatayengin evaluationoflvadinfectionsinatertiaryuniversityhospitalcohort